share_log

微創醫療:截至二零二三年十二月三十一日止年度之全年業績預告之更新

MICROPORT: UPDATE ON THE ESTIMATED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023

香港交易所 ·  Mar 22 09:01
Summary by Moomoo AI
微創醫疗科學有限公司於2024年3月22日更新了截至2023年12月31日止年度的全年業績預告。該公司預計報告期內虧損將不超過650百萬美元。此項更新是基於公司進一步評估後所作出的初步評估,並未經獨立核數師或審核委員會審核或審閱。微創醫疗提醒股東及潛在投資者注意,該預告的完整年度業績將於2024年3月末前公布,並建議在交易公司股份及證券時應審慎行事。
微創醫疗科學有限公司於2024年3月22日更新了截至2023年12月31日止年度的全年業績預告。該公司預計報告期內虧損將不超過650百萬美元。此項更新是基於公司進一步評估後所作出的初步評估,並未經獨立核數師或審核委員會審核或審閱。微創醫疗提醒股東及潛在投資者注意,該預告的完整年度業績將於2024年3月末前公布,並建議在交易公司股份及證券時應審慎行事。
MicroChung Medical Sciences Limited updated its annual results forecast for the year ended December 31, 2023 on March 22, 2024. The company expects a loss during the reporting period of no more than $650 million. This update is based on an initial assessment made by the Company after further evaluation and has not been reviewed or reviewed by an independent auditor or audit committee. Micro-CHO reminds shareholders and potential investors that the announcement of its full annual results will be released by the end of March 2024 and advises to exercise caution when trading the company's shares and securities.
MicroChung Medical Sciences Limited updated its annual results forecast for the year ended December 31, 2023 on March 22, 2024. The company expects a loss during the reporting period of no more than $650 million. This update is based on an initial assessment made by the Company after further evaluation and has not been reviewed or reviewed by an independent auditor or audit committee. Micro-CHO reminds shareholders and potential investors that the announcement of its full annual results will be released by the end of March 2024 and advises to exercise caution when trading the company's shares and securities.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more